Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 68

1.

Antithrombotic use and bleeding risk in patients with atrial fibrillation: findings from a multipayer analysis.

Lang K, Federico V, Patel AA, Munsell M, Nelson WW, Owens G, Mody SH, Schein J, Menzin J.

J Comp Eff Res. 2016 Jan;5(1):39-48. doi: 10.2217/cer.15.48. Epub 2015 Dec 21.

PMID:
26690040
2.

Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure.

McHorney CA, Crivera C, Laliberté F, Nelson WW, Germain G, Bookhart B, Martin S, Schein J, Lefebvre P, Deitelzweig S.

Curr Med Res Opin. 2015 Dec;31(12):2167-73. doi: 10.1185/03007995.2015.1096242. Epub 2015 Oct 22.

PMID:
26393483
3.

Medication persistence and discontinuation of rivaroxaban and dabigatran etexilate among patients with non-valvular atrial fibrillation.

Nelson WW, Song X, Thomson E, Smith DM, Coleman CI, Damaraju CV, Schein JR.

Curr Med Res Opin. 2015;31(10):1831-40. doi: 10.1185/03007995.2015.1074064. Epub 2015 Sep 4.

PMID:
26211816
4.

Pharmacy quality alliance measure: adherence to non-warfarin oral anticoagulant medications.

Crivera C, Nelson WW, Bookhart B, Martin S, Germain G, Laliberté F, Schein J, Lefebvre P.

Curr Med Res Opin. 2015;31(10):1889-95. doi: 10.1185/03007995.2015.1077213. Epub 2015 Sep 4.

PMID:
26211815
5.

International normalized ratio stability in warfarin-experienced patients with nonvalvular atrial fibrillation.

Nelson WW, Desai S, Damaraju CV, Lu L, Fields LE, Wildgoose P, Schein JR.

Am J Cardiovasc Drugs. 2015 Jun;15(3):205-11. doi: 10.1007/s40256-015-0120-9.

6.

Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users.

Laliberté F, Cloutier M, Crivera C, Nelson WW, Olson WH, Schein J, Vanderpoel J, Germain G, Lefebvre P.

Adv Ther. 2015 Apr;32(4):387. doi: 10.1007/s12325-015-0202-8. No abstract available.

7.

Effect of rivaroxaban versus warfarin on health care costs among nonvalvular atrial fibrillation patients: observations from rivaroxaban users and matched warfarin users.

Laliberté F, Cloutier M, Crivera C, Nelson WW, Olson WH, Schein J, Vanderpoel J, Germain G, Lefebvre P.

Adv Ther. 2015 Mar;32(3):216-27. doi: 10.1007/s12325-015-0189-1. Epub 2015 Mar 18. Erratum in: Adv Ther. 2015 Apr;32(4):387.

8.

Effects of rivaroxaban versus warfarin on hospitalization days and other health care resource utilization in patients with nonvalvular atrial fibrillation: an observational study from a cohort of matched users.

Laliberté F, Cloutier M, Crivera C, Nelson WW, Olson WH, Schein J, Vanderpoel J, Germain G, Lefebvre P.

Clin Ther. 2015 Mar 1;37(3):554-62. doi: 10.1016/j.clinthera.2015.02.001. Epub 2015 Mar 4. Erratum in: Clin Ther. 2015 Aug;37(8):1870-1.

9.

Nurses' self-reported time estimation of anticoagulation therapy: a survey of warfarin management in long-term care.

Patel AA, Nelson WW.

BMC Nurs. 2015 Feb 21;14:8. doi: 10.1186/s12912-015-0058-x. eCollection 2015.

10.

Out-of-range international normalized ratio values and healthcare cost among new warfarin patients with non-valvular atrial fibrillation.

Nelson WW, Wang L, Baser O, Damaraju CV, Schein JR.

J Med Econ. 2015 May;18(5):333-40. doi: 10.3111/13696998.2014.1001851. Epub 2015 Feb 6.

PMID:
25549062
11.

Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation.

Nelson WW, Wang L, Baser O, Damaraju CV, Schein JR.

Int J Clin Pharm. 2015 Feb;37(1):53-9. doi: 10.1007/s11096-014-0038-3. Epub 2014 Nov 27.

12.

Hospital length of stay of nonvalvular atrial fibrillation patients who were administered Rivaroxaban versus Warfarin with and without pretreatment parenteral anticoagulants therapies.

Laliberté F, Pilon D, Raut MK, Nelson WW, Olson WH, Germain G, Schein JR, Lefebvre P.

Hosp Pract (1995). 2014 Aug;42(3):17-25. doi: 10.3810/hp.2014.08.1114.

PMID:
25255403
13.

International normalized ratio stabilization in newly initiated warfarin patients with nonvalvular atrial fibrillation.

Nelson WW, Desai S, Damaraju CV, Lu L, Fields LE, Wildgoose P, Schein JR.

Curr Med Res Opin. 2014 Dec;30(12):2437-42. doi: 10.1185/03007995.2014.957822. Epub 2014 Sep 2.

PMID:
25170587
14.

Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillation.

Nelson WW, Song X, Coleman CI, Thomson E, Smith DM, Damaraju CV, Schein JR.

Curr Med Res Opin. 2014 Dec;30(12):2461-9. doi: 10.1185/03007995.2014.933577. Epub 2014 Jun 25.

PMID:
24926732
15.

Is rivaroxaban associated with lower inpatient costs compared to warfarin among patients with non-valvular atrial fibrillation?

Laliberté F, Pilon D, Raut MK, Nelson WW, Olson WH, Germain G, Schein JR, Lefebvre P.

Curr Med Res Opin. 2014 Aug;30(8):1521-8. doi: 10.1185/03007995.2014.916159. Epub 2014 May 2.

PMID:
24758611
16.

Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients.

Laliberté F, Cloutier M, Nelson WW, Coleman CI, Pilon D, Olson WH, Damaraju CV, Schein JR, Lefebvre P.

Curr Med Res Opin. 2014 Jul;30(7):1317-25. doi: 10.1185/03007995.2014.907140. Epub 2014 Apr 2.

PMID:
24650301
17.

Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation.

Choi JC, Dibonaventura MD, Kopenhafer L, Nelson WW.

Patient Prefer Adherence. 2014 Feb 7;8:167-77. doi: 10.2147/PPA.S56187. eCollection 2014.

18.

The economic burden to medicare of stroke events in atrial fibrillation populations with and without thromboprophylaxis.

Patel AA, Ogden K, Veerman M, Mody SH, Nelson WW, Neil N.

Popul Health Manag. 2014 Jun;17(3):159-65. doi: 10.1089/pop.2013.0056. Epub 2014 Jan 29.

19.

Hospital length of stay: is rivaroxaban associated with shorter inpatient stay compared to warfarin among patients with non-valvular atrial fibrillation?

Laliberté F, Pilon D, Raut MK, Nelson WW, Olson WH, Germain G, Schein JR, Lefebvre P.

Curr Med Res Opin. 2014 Apr;30(4):645-53. doi: 10.1185/03007995.2013.867843. Epub 2013 Dec 5.

PMID:
24256067
20.

Persistence of warfarin therapy for residents in long-term care who have atrial fibrillation.

Patel AA, Reardon G, Nelson WW, Philpot T, Neidecker MV.

Clin Ther. 2013 Nov;35(11):1794-804. doi: 10.1016/j.clinthera.2013.09.010. Epub 2013 Oct 15.

PMID:
24139051
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk